| Title | Author | Year | SCOPUS | PUBMED | ISI | TCI | |
|---|---|---|---|---|---|---|---|
| 1. | Redox modulation and human bile duct cancer inhibition by curcumin. | Suphim, B Prawan, A Kukongviriyapan, U Kongpetch, S Buranrat, B Kukongviriyapan, V |
0 | ||||
| 2. | Dicoumarol enhances gemcitabine-induced cytotoxicity in high NQ01-expressing cholangiocarcinoma cells | Benjaporn Buranrat Auemduan Prawan Upa Kukongviriyapan Sarinya Kongpetch Veerapol Kukongviriyapan |
2010 | ||||
| 3. | Dicoumarol enhances gemcitabine-induced cytotoxicity in high NQO1-expressing cholangiocarcinoma cells. | Buranrat, B. Prawan, A. Kukongviriyapan, U. Kongpetch, S. Kukongviriyapan, V. |
2010 | ||||
| 4. | Redox modulation and human bile duct cancer inhibition by curcumin | Suphim, B. Prawan, A. Kukongviriyapan, U. Kongpetch, S. Buranrat, B. Kukongviriyapan, V. |
2010 | ||||
| 5. | Crucial Role of Heme Oxygenase-1 on the Sensitivity of Cholangiocarcinoma Cells to Chemotherapeutic Agents | Kongpetch, S. Kukongviriyapan, V. Prawan, A. Senggunprai, L. Kukongviriyapan, U. Buranrat, B. |
2012 | ||||
| 6. | Heme oxygenase-1 as a potential target for anticancer treatments in cholangiocarcinoma | S. Kongpetch V. Kukongviriyapan A. Prawan L. Senggunprai U. Kukongviriyapan O. C. Kiat W. Chan-On S. E. Yan T. B. Tean |
2012 | ||||
| 7. | Inhibition of Heme Oxygenase-1 Enhanced Antitumor Effect of Gemcitabine in Cholangiocarcinoma | Sarinya Kongpetch | 2013 | ||||
| 8. | Luteolin arrests cell cycling, induces apoptosis and inhibits the JAK/STAT3 pathway in human cholangiocarcinoma cells. | Ploypailin Aneknan Veerapol Kukongviriyapan Auemduan Prawan Sarinya Kongpetch Banchob Sripa Laddawan Senggunprai |
2014 | ||||
| 9. | Fumarate Hydratase-deficient Cell Line NCCFH1 as a New In Vitro Model of Hereditary Papillary Renal Cell Carcinoma Type 2 | Perrier-Trudova, V Huimin, BW Kongpetch, S Huang, D Ong, P LE Formal, A Poon, SL Siew, EY Myint, SS Gad, S Gardie, B Couvé, S Foong, YM Choudhury, Y Poh, J Ong, CK Toh, CK Ooi, A Richard, S Tan, MH Teh, BT |
2015 | ||||
| 10. | Genetics of Opisthorchis viverrini-related cholangiocarcinoma. | Jusakul, A. Kongpetch, S. |
2015 | ||||
| 11. | Pathogenesis of cholangiocarcinoma: From genetics to signalling pathways | Kongpetch, S Jusakul, A Ong, CK Lim, WK Rozen, SG Tan, P Teh, BT |
2015 | ||||
| 12. | Haem oxygenase 1 expression is associated with prognosis in cholangiocarcinoma patients and with drug sensitivity in xenografted mice | Kongpetch, S Puapairoj, A Ong, CK Senggunprai, L Prawan, A Kukongviriyapan, U Chan-On, W Siew, EY Khuntikeo, N Teh, BT Kukongviriyapan, V |
2016 | ||||
| 13. | Downregulation of NAD(P)H:quinone oxidoreductase 1 inhibits proliferation, cell cycle and migration of cholangiocarcinoma cells. | Kukongviriyapan, V. Senggunprai, L. Kongpetch, S. Zeekpudsa, P. Prawan, A. |
2017 | ||||
| 14. | Establishment of cholangiocarcinoma cell lines from patients in the endemic area of liver fluke infection in Thailand | Senggunprai, L. Namwat, N. Kongpetch, S. Chamgramol, Y. Loilome, W. Khansaard, W. Jusakul, A. Prawan, A. Pairojkul, C. Yongvanit, P. Kukongviriyapan, V. |
2017 | ||||
| 15. | SILENCING OF NAD(P) H: QUINONE OXIDOREDUCTASE 1 DECREASES THE CELL GROWTH AND MIGRATION OF CHOLANGIOCARCINOMA CELLS | Auemduan Prawan Siriwoot Butsri Veerapol Kukongviriyapan Laddawan Senggunprai Sarinya Kongpetch |
2017 | ||||
| 16. | Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma. | Jusakul, A. Cutcutache, I. Kongpetch, S. Myint, S.S. Thanan, R. Ng, C.C.Y. Rajasegaran, V. McPherson, J.R. Khuntikeo, N. Bhudhisawasdi, V. Yongvanit, P. Dima, S.O.L. Shibata, T. Pairojkul, C. |
2017 | ||||
| 17. | Antitumor effects of candidone, a natural flavanone derivative, in cholangiocarcinoma cells | Sarinya Kongpetch Benjawan Kurasug Veerapol Kukongviriyapan Auemduan Prawan Laddawan Senggunprai Chavi Yenjai |
2018 | ||||
| 18. | Antitumor effects of candidone extracted from Derris indica (Lamk) Bennet in cholangiocarcinoma cells | Kukongviriyapan, V. Prawan, A. Yenjai, C. Kongpetch, S. |
2018 | ||||
| 19. | Cucurbitacin B induces apoptosis in human cholangiocarcinoma cells by modulation of apoptotic-related proteins | Sirinapha Klungsaeng Laddawan Senggunprai Veerapol Kukongviriyapan Auemduan Prawan Sarinya Kongpetch |
2018 | ||||
| 20. | Metformin enhances cisplatin induced inhibition of cholangiocarcinoma cells via AMPK-mTOR pathway | Wandee, J Prawan, A Senggunprai, L Kongpetch, S Tusskorn, O Kukongviriyapan, V |
2018 | ||||
| 21. | Migration of Pancreatic Cancer cell BxPC-3 is suppressed by ROS | Jaroon Wandee Auemduan Prawan Laddawan Senggunprai Sarinya Kongpetch Veerapol Kukongviriyapan |
2018 | ||||
| 22. | Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma | Apinya Jusakul Ioana Cutcutache Chern Han Yong Jing Quan Lim Mi Ni Huang Nisha Padmanabhan Vishwa Nellore Sarinya Kongpetch Alvin Wei Tian Ng Ley Moy Ng Su Pin Choo Swe Swe Myint Raynoo Thanan Sanjanaa Nagarajan Weng Khong Lim Cedric Chuan Young Ng Arnoud Boot Mo Liu Choon Kiat Ong Vikneswari Rajasegaran Stefanus Lie Alvin Soon Tiong Lim Tse Hui Lim Jing Tan Jia Liang Loh John R. McPherson Narong Khuntikeo Vajaraphongsa Bhudhisawasdi Puangrat Yongvanit Sopit Wongkham Yasushi Totoki Hiromi Nakamura Yasuhito Arai Satoshi Yamasaki Pierce Kah-Hoe Chow Alexander Yaw Fui Chung London Lucien Peng Jin Ooi Kiat Hon Lim Simona Dima Dan G. Duda Irinel Popescu Philippe Broet Sen-Yung Hsieh Ming-Chin Yu Aldo Scarpa Jiaming Lai Di-Xian Luo Andre Lopes Carvalho Andre Luiz Vettore Hyungjin Rhee Young Nyun Park Ludmil B. Alexandrov Raluca Gordan Steven G. Rozen Tatsuhiro Shibata Chawalit Pairojkul Bin Tean Teh Patrick Tan |
2018 | ||||
| 23. | Cucurbitacin B induces mitochondrial-mediated apoptosis pathway in cholangiocarcinoma cells via suppressing focal adhesion kinase signaling | Sirinapha Klungsaeng Veerapol Kukongviriyapan Auemduan Prawan Sarinya Kongpetch Laddawan Senggunprai |
2019 | ||||
| 24. | Metformin sensitizes cholangiocarcinoma cell to cisplatin-induced cytotoxicity through oxidative stress mediated mitochondrial pathway. | Prawan, A. Senggunprai, L. Kongpetch, S. Kukongviriyapan, V. |
2019 | ||||
| 25. | Myricetin ameliorates cytokine-induced migration and invasion of cholangiocarcinoma cells via suppression of STAT3 pathway. | Pattarapon Tuponchai Veerapol Kukongviriyapan Auemduan Prawan Sarinya Kongpetch Laddawan Senggunprai |
2019 | ||||
| 26. | Lack of targetable FGFR2 fusions in endemic fluke-associated cholangiocarcinoma | Sarinya Kongpetch Apinya Jusakul Jing Quan Lim Cedric Chuan Young Ng Jason Yongsheng Chan Vikneswari Rajasegaran Tse Hui Lim Kiat Hon Lim Su Pin Choo Simona Dima Irinel Popescu Dan G. Duda Veerapol Kukongviriyapan Narong Khuntikeo Chawalit Pairojkul Steven G. Rozen Patrick Tan Bin Tean Teh |
2020 | ||||
| 27. | Phenformin inhibits proliferation, invasion, and angiogenesis of cholangiocarcinoma cells via AMPK-mTOR and HIF-1A pathways. | Kongpetch, S. Senggunprai, L. Prawan, A. Kukongviriyapan, U. Kukongviriyapan, V. |
2020 | ||||
| 28. | Rice bran hydrolysates induce immunomodulatory effects by suppression of chemotaxis, and modulation of cytokine release and cell-mediated cytotoxicity | Suphanthip Phusrisom Laddawan Senggunprai Auemduan Prawan Sarinya Kongpetch Upa Kukongviriyapan Supawan Thawornchinsombut Ronnachai Changsri Veerapol Kukongviriyapan |
2020 | ||||
| 29. | Targeted modulation of FAK/PI3K/PDK1/AKT and FAK/p53 pathways by cucurbitacin B for the antiproliferation effect against human cholangiocarcinoma cells | Klungsaeng, S Kukongviriyapan, V Prawan, A Kongpetch, S Senggunprai, L |
2020 | ||||
| 30. | Anti-tumor activity of rice bran hydrolysates on migration, invasion and angiogenesis | Suphanthip Phusrisom Laddawan Senggunprai Auemduan Prawan Sarinya Kongpetch Upa Kukongviriyapan Supawan Thawornchinsombut Sirithon Siriamornpun Theeraphan Chumroenphat Ronnachai Changsri Veerapol Kukongviriyapan |
2021 | ||||
| 31. | Arctigenin inhibits cholangiocarcinoma progression by regulating cell migration and cell viability via the N-cadherin and apoptosis pathway | Jusakul, A. Kongpetch, S. Kimawaha, P. Klanrit, P. Loilome, W. Namwat, N. Techasen, A. |
2021 | ||||
| 32. | Cucurbitacin B Diminishes Metastatic Behavior of Cholangiocarcinoma Cells by Suppressing Focal Adhesion Kinase | Kaewmeesri, P Kukongviriyapan, V Prawan, A Kongpetch, S Senggunprai, L |
2021 | ||||
| 33. | Derrischalcone suppresses cholangiocarcinoma cells through targeting ROS-mediated mitochondrial cell death, Akt/mTOR, and FAK pathways. | Prawan, A. Senggunprai, L. Kongpetch, S. Yenjai, C. Kukongviriyapan, V. |
2021 | ||||
| 34. | Diagnostic and Prognostic Value of Circulating Cell-Free DNA for Cholangiocarcinoma | Preawwalee Wintachai Jing Quan Lim Anchalee Techasen Worachart Lert-Itthiporn Sarinya Kongpetch Watcharin Loilome Jarin Chindaprasirt Attapol Titapun Nisana Namwat Narong Khuntikeo Apinya Jusakul |
2021 | ||||
| 35. | Diagnostic and prognostic value of circulating cell‐free dna for cholangiocarcinoma | Wintachai, P. Techasen, A. Lert-Itthiporn, W. Kongpetch, S. Loilome, W. Titapun, A. Namwat, N. Khuntikeo, N. Jusakul, A. |
2021 | ||||
| 36. | Targeting FGFR inhibition in cholangiocarcinoma | Kongpetch, S. | 2021 | ||||
| 37. | All--retinoic acid induces RARB-dependent apoptosis via ROS induction and enhances cisplatin sensitivity by NRF2 downregulation in cholangiocarcinoma cells. | Butsri, S Kukongviriyapan, V Senggunprai, L Kongpetch, S Prawan, A |
2022 | ||||
| 38. | All-trans-retinoic acid induces RARB-dependent apoptosis via ROS induction and enhances cisplatin sensitivity by NRF2 downregulation in cholangiocarcinoma cells | Butsri, S. Kukongviriyapan, V. Senggunprai, L. Kongpetch, S. Prawan, A. |
2022 | ||||
| 39. | Anti-metastatic Potential of Natural Triterpenoid Cucurbitacin B Against Cholangiocarcinoma Cells by Targeting Src Protein. | Kaewmeesri, P. Pocasap, P. Kukongviriyapan, V. Prawan, A. Kongpetch, S. Senggunprai, L. |
2022 | ||||
| 40. | Epidermal growth factor receptor as a potential target of momordin Ic to promote apoptosis of cholangiocarcinoma cells. | Senggunprai, L. Kukongviriyapan, V. Prawan, A. Kongpetch, S. |
2022 | ||||
| 41. | Inhibition of FGFR2 enhances chemosensitivity to gemcitabine in cholangiocarcinoma through the AKT/mTOR and EMT signaling pathways | Jaidee, R Kukongviriyapan, V Senggunprai, L Prawan, A Jusakul, A Laphanuwat, P Kongpetch, S |
2022 | ||||
| 42. | Licochalcone A Induces Cholangiocarcinoma Cell Death Via Suppression of Nrf2 and NF-κB Signaling Pathways | Laphanuwat, P Kongpetch, S Senggunprai, L Prawan, A Kukongviriyapan, V |
2022 | ||||
| 43. | Therapeutic targeting of ARID1A and PI3K/AKT pathway alterations in cholangiocarcinoma | Tessiri, S Techasen, A Kongpetch, S Namjan, A Loilome, W Chan-On, W Thanan, R Jusakul, A |
2022 | ||||
| 44. | 13-cis-retinoic acid inhibits the self-renewal, migration, invasion and adhesion of cholangiocarcinoma cells | Butsri, S. Kukongviriyapan, V. Senggunprai, L. Kongpetch, S. Prawan, A. |
2023 | ||||
| 45. | Alteration of STK11 Expression Associated With Cholangiocarcinoma Progression. | Sirithawat, P Jusakul, A Kongpetch, S Thanee, M Srichanchara, P Panjaroensak, S Kimawaha, P Janthamala, S Aphivatanasiri, C Techasen, A |
2023 | ||||
| 46. | FGF10/FGFR2 Signaling: Therapeutically Targetable Vulnerability in Ligand-responsive Cholangiocarcinoma Cells. | Oeurn, K Jusakul, A Jaidee, R Kukongviriyapan, V Senggunprai, L Prawan, A Kongpetch, S |
2023 | ||||
| 47. | Anticancer properties and metabolomic profiling of Shorea roxburghii extracts toward gastrointestinal cancer cell lines | Janthamala, S Promraksa, B Thanee, M Duenngai, K Jusakul, A Kongpetch, S Kraiklang, R Thanee, K Pinlaor, P Namwat, N Saya, H Techasen, A |
2024 | ||||
| 48. | Dual blockage of PI3K-mTOR and FGFR induced autophagic cell death in cholangiocarcinoma cells. | Mahaamnad, N Pocasap, P Kukongviriyapan, V Senggunprai, L Prawan, A Kongpetch, S |
2024 | ||||
| 49. | Integrative multiomics enhancer activity profiling identifies therapeutic vulnerabilities in cholangiocarcinoma of different etiologies. | Hong, JH Yong, CH Heng, HL Chan, JY Lau, MC Chen, J Lee, JY Lim, AH Li, Z Guan, P Chu, PL Boot, A Ng, SR Yao, X Wee, FYT Lim, JCT Liu, W Wang, P Xiao, R Zeng, X Sun, Y Koh, J Kwek, XY Ng, CCY Klanrit, P Zhang, Y Lai, J Tai, DWM Pairojkul, C Dima, S Popescu, I Hsieh, SY Yu, MC Yeong, J Kongpetch, S Jusakul, A Loilome, W Tan, P Tan, J Teh, BT |
2024 | ||||
| 50. | Network pharmacology- and cell-based assessments identify the FAK/Src pathway as a molecular target for the antimetastatic effect of momordin Ic against cholangiocarcinoma. | Pocasap, P Prawan, A Kongpetch, S Senggunprai, L |
2024 | ||||
| 51. | Establishment and genomic profiling of cholangiocarcinoma cells with functional characterization. | Jaidee, R Jusakul, A Pocasap, P Kukongviriyapan, V Senggunprai, L Prawan, A Loilome, W Titapun, A Jareanrat, A Thanasukarn, V Khuntikeo, N Namwat, N Chamgramol, Y Thanee, M Wichian, P Hong, JH Guan, P Heng, HL Pairojkul, C Teh, BT Kongpetch, S |
2025 | ||||
| 52. | Expression and Prognostic Implication of the Nuclear Receptors Farnesoid X Receptor and Pregnane X Receptor in Human Cholangiocarcinoma. | Sa-Ngiamwibool, P Yoshinari, K Shizu, R Kongpetch, S Prawan, A Senggunprai, L |
2025 | ||||
| 53. | Mutations in Cholangiocarcinoma: Prevalence, Prognostic Value, and G12/G13 Detection in Cell-Free DNA. | Thongyoo, P Chindaprasirt, J Aphivatanasiri, C Intarawichian, P Kunprom, W Kongpetch, S Techasen, A Loilome, W Namwat, N Titapun, A Jusakul, A |
2025 | ||||
| 54. | Synergistic suppression of cholangiocarcinoma cells via DNA damage response and cell cycle arrest by dual targeting PARP and ATM in DNA damage repair pathway. | Jaidee, R Pocasap, P Jusakul, A Senggunprai, L Prawan, A Hong, JH Heng, HL Kukongviriyapan, V Teh, BT Kongpetch, S |
2025 | Count | 33 | 37 | 29 | 1 |
| Title | Authors | Year | Publication name | Cited count | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| < 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Total | ||||||
| 1. | Dicoumarol enhances gemcitabine-induced cytotoxicity in high NQO1-expressing cholangiocarcinoma cells | Buranrat, B. Prawan, A. Kukongviriyapan, U. Kongpetch, S. Kukongviriyapan, V. |
2010 |
World Journal of Gastroenterology 19 (16), pp. 2362-2370 |
||||||||
| 2. | Redox modulation and human bile duct cancer inhibition by curcumin | Suphim, B. Prawan, A. Kukongviriyapan, U. Kongpetch, S. Buranrat, B. Kukongviriyapan, V. |
2010 |
Food and Chemical Toxicology 8-9 (48), pp. 2265-2272 |
||||||||
| 3. | Crucial role of heme oxygenase-1 on the sensitivity of cholangiocarcinoma cells to chemotherapeutic agents | Kongpetch, S. Kukongviriyapan, V. Prawan, A. Senggunprai, L. Kukongviriyapan, U. Buranrat, B. |
2012 |
PLoS ONE 4 (7), pp. |
||||||||
| 4. | Luteolin arrests cell cycling, induces apoptosis and inhibits the JAK/STAT3 pathway in human cholangiocarcinoma cells | Aneknan, P. Kukongviriyapan, V. Prawan, A. Kongpetch, S. Sripa, B. Senggunprai, L. |
2014 |
Asian Pacific Journal of Cancer Prevention 12 (15), pp. 5071-5076 |
||||||||
| 5. | Genetics of Opisthorchis viverrini -related cholangiocarcinoma | Jusakul, A. Kongpetch, S. |
2015 |
Current Opinion in Gastroenterology 3 (31), pp. 258-263 |
||||||||
| 6. | Pathogenesis of cholangiocarcinoma: From genetics to signalling pathways | Kongpetch, S. Jusakul, A. Ong, C. Lim, W. |
2015 |
Best Practice and Research: Clinical Gastroenterology 2 (29), pp. 233-244 |
||||||||
| 7. | Haem oxygenase 1 expression is associated with prognosis in cholangiocarcinoma patients and with drug sensitivity in xenografted mice | Kongpetch, S. Puapairoj, A. Senggunprai, L. Prawan, A. Kukongviriyapan, U. Chan-On, W. Khuntikeo, N. Kukongviriyapan, V. |
2016 |
Cell Proliferation 1 (49), pp. 90-101 |
||||||||
| 8. | Downregulation of NAD(P)H:Quinone oxidoreductase 1 inhibits proliferation, cell cycle and migration of cholangiocarcinoma cells | Kukongviriyapan, V. Senggunprai, L. Kongpetch, S. Zeekpudsa, P. Prawan, A. |
2017 |
Oncology Letters 6 (13), pp. 4540-4548 |
||||||||
| 9. | Establishment of cholangiocarcinoma cell lines from patients in the endemic area of liver fluke infection in Thailand | Senggunprai, L. Namwat, N. Kongpetch, S. Chamgramol, Y. Loilome, W. Khansaard, W. Jusakul, A. Prawan, A. Pairojkul, C. Yongvanit, P. Kukongviriyapan, V. |
2017 |
Tumor Biology 11 (39), pp. |
||||||||
| 10. | Whole-genome and epigenomic landscapes of etiologically distinct subtypes of cholangiocarcinoma | Jusakul, A. Cutcutache, I. Kongpetch, S. Myint, S.S. Thanan, R. Ng, C.C.Y. Rajasegaran, V. McPherson, J.R. Khuntikeo, N. Bhudhisawasdi, V. Yongvanit, P. Dima, S.O.L. Shibata, T. Pairojkul, C. |
2017 |
Cancer Discovery 10 (7), pp. 1116-1135 |
||||||||
| 11. | Antitumor effects of candidone extracted from Derris indica (Lamk) Bennet in cholangiocarcinoma cells | Kukongviriyapan, V. Prawan, A. Yenjai, C. Kongpetch, S. |
2018 |
Tropical Journal of Pharmaceutical Research 7 (17), pp. 1337-1343 |
||||||||
| 12. | Metformin enhances cisplatin induced inhibition of cholangiocarcinoma cells via AMPK-mTOR pathway | Prawan, A. Senggunprai, L. Kongpetch, S. Tusskorn, O. Kukongviriyapan, V. |
2018 |
Life Sciences (207), pp. 172-183 |
||||||||
| 13. | Cucurbitacin B induces mitochondrial-mediated apoptosis pathway in cholangiocarcinoma cells via suppressing focal adhesion kinase signaling | Kukongviriyapan, V. Prawan, A. Kongpetch, S. Senggunprai, L. |
2019 |
Naunyn-Schmiedeberg's Archives of Pharmacology 3 (392), pp. 271-278 |
||||||||
| 14. | Metformin sensitizes cholangiocarcinoma cell to cisplatin-induced cytotoxicity through oxidative stress mediated mitochondrial pathway | Prawan, A. Senggunprai, L. Kongpetch, S. Kukongviriyapan, V. |
2019 |
Life Sciences (217), pp. 155-163 |
||||||||
| 15. | Myricetin ameliorates cytokine-induced migration and invasion of cholangiocarcinoma cells via suppression of STAT3 pathway | Kukongviriyapan, V. Prawan, A. Kongpetch, S. Senggunprai, L. |
2019 |
Journal of Cancer Research and Therapeutics 1 (15), pp. 157-163 |
||||||||
| 16. | Lack of targetable FGFR2 fusions in endemic fluke-associated cholangiocarcinoma | Kongpetch, S. Jusakul, A. Ng, C.C.Y. Rajasegaran, V. Dima, S.O.L. Kukongviriyapan, V. Khuntikeo, N. Pairojkul, C. |
2020 |
JCO Global Oncology (6), pp. 628-638 |
||||||||
| 17. | Phenformin inhibits proliferation, invasion, and angiogenesis of cholangiocarcinoma cells via AMPK-mTOR and HIF-1A pathways | Kongpetch, S. Senggunprai, L. Prawan, A. Kukongviriyapan, U. Kukongviriyapan, V. |
2020 |
Naunyn-Schmiedeberg's Archives of Pharmacology 9 (393), pp. 1681-1690 |
||||||||
| 18. | Rice bran hydrolysates induce immunomodulatory effects by suppression of chemotaxis, and modulation of cytokine release and cell-mediated cytotoxicity | Senggunprai, L. Prawan, A. Kongpetch, S. Kukongviriyapan, U. Thawornchinsombut, S. Kukongviriyapan, V. |
2020 |
Asian Pacific Journal of Tropical Biomedicine 10 (10), pp. 470-478 |
||||||||
| 19. | Targeted modulation of FAK/PI3K/PDK1/AKT and FAK/p53 pathways by cucurbitacin B for the antiproliferation effect against human cholangiocarcinoma cells | Kukongviriyapan, V. Prawan, A. Kongpetch, S. Senggunprai, L. |
2020 |
American Journal of Chinese Medicine 6 (48), pp. 1475-1489 |
||||||||
| 20. | Anti-tumor activity of rice bran hydrolysates on migration, invasion and angiogenesis | Phusrisom, S. Senggunprai, L. Prawan, A. Kongpetch, S. Kukongviriyapan, U. Thawornchinsombut, S. Changsri, R. Kukongviriyapan, V. |
2021 |
Asian Pacific Journal of Tropical Biomedicine 7 (11), pp. 317-326 |
||||||||
| 21. | Arctigenin inhibits cholangiocarcinoma progression by regulating cell migration and cell viability via the N-cadherin and apoptosis pathway | Jusakul, A. Kongpetch, S. Kimawaha, P. Klanrit, P. Loilome, W. Namwat, N. Techasen, A. |
2021 |
Naunyn-Schmiedeberg's Archives of Pharmacology 10 (394), pp. 2049-2059 |
||||||||
| 22. | Cucurbitacin B Diminishes Metastatic Behavior of Cholangiocarcinoma Cells by Suppressing Focal Adhesion Kinase | Kukongviriyapan, V. Prawan, A. Kongpetch, S. Senggunprai, L. |
2021 |
Asian Pacific Journal of Cancer Prevention 1 (22), pp. 219-225 |
||||||||
| 23. | Derrischalcone suppresses cholangiocarcinoma cells through targeting ROS-mediated mitochondrial cell death, Akt/mTOR, and FAK pathways | Prawan, A. Senggunprai, L. Kongpetch, S. Yenjai, C. Kukongviriyapan, V. |
2021 |
Naunyn-Schmiedeberg's Archives of Pharmacology 9 (394), pp. 1929-1940 |
||||||||
| 24. | Diagnostic and prognostic value of circulating cell‐free dna for cholangiocarcinoma | Wintachai, P. Techasen, A. Lert-Itthiporn, W. Kongpetch, S. Loilome, W. Titapun, A. Namwat, N. Khuntikeo, N. Jusakul, A. |
2021 |
Diagnostics 6 (11), pp. |
||||||||
| 25. | Targeting FGFR inhibition in cholangiocarcinoma | Kongpetch, S. | 2021 |
Cancer Treatment Reviews (95), pp. |
||||||||
| 26. | All-trans-retinoic acid induces RARB-dependent apoptosis via ROS induction and enhances cisplatin sensitivity by NRF2 downregulation in cholangiocarcinoma cells | Butsri, S. Kukongviriyapan, V. Senggunprai, L. Kongpetch, S. Prawan, A. |
2022 |
Oncology Letters 6 (23), pp. |
||||||||
| 27. | Anti-metastatic Potential of Natural Triterpenoid Cucurbitacin B Against Cholangiocarcinoma Cells by Targeting Src Protein | Kaewmeesri, P. Pocasap, P. Kukongviriyapan, V. Prawan, A. Kongpetch, S. Senggunprai, L. |
2022 |
Integrative Cancer Therapies (21), pp. |
||||||||
| 28. | Epidermal growth factor receptor as a potential target of momordin Ic to promote apoptosis of cholangiocarcinoma cells | Senggunprai, L. Kukongviriyapan, V. Prawan, A. Kongpetch, S. |
2022 |
Journal of Pharmacy and Pharmacology 7 (74), pp. 996-1005 |
||||||||
| 29. | Inhibition of FGFR2 enhances chemosensitivity to gemcitabine in cholangiocarcinoma through the AKT/mTOR and EMT signaling pathways | Jaidee, R. Kukongviriyapan, V. Senggunprai, L. Prawan, A. Jusakul, A. Laphanuwat, P. Kongpetch, S. |
2022 |
Life Sciences (296), pp. |
||||||||
| 30. | Licochalcone A Induces Cholangiocarcinoma Cell Death Via Suppression of Nrf2 and NF-κB Signaling Pathways | Laphanuwat, P. Kongpetch, S. Senggunprai, L. Prawan, A. Kukongviriyapan, V. |
2022 |
Asian Pacific Journal of Cancer Prevention 1 (23), pp. 115-123 |
||||||||
| 31. | Therapeutic targeting of ARID1A and PI3K/AKT pathway alterations in cholangiocarcinoma | Techasen, A. Kongpetch, S. Namjan, A. Loilome, W. Chan-On, W. Thanan, R. Jusakul, A. |
2022 |
PeerJ (10), pp. |
||||||||
| 32. | 13-cis-retinoic acid inhibits the self-renewal, migration, invasion and adhesion of cholangiocarcinoma cells | Butsri, S. Kukongviriyapan, V. Senggunprai, L. Kongpetch, S. Prawan, A. |
2023 |
International Journal of Molecular Medicine 3 (51), pp. |
||||||||
| 33. | Anticancer properties and metabolomic profiling of Shorea roxburghii extracts toward gastrointestinal cancer cell lines | Janthamala, S. Promraksa, B. Thanee, M. Duenngai, K. Jusakul, A. Kongpetch, S. Kraiklang, R. Thanee, K. Pinlaor, P. Namwat, N. Saya, H. Techasen, A. |
2024 |
BMC Complementary Medicine and Therapies 1 (24), pp. |
||||||||
| Title | Authors | Year | Journal title | ||
|---|---|---|---|---|---|
| 1. | Dicoumarol enhances gemcitabine-induced cytotoxicity in high NQO1-expressing cholangiocarcinoma cells. | Buranrat, B Prawan, A Kukongviriyapan, U Kongpetch, S Kukongviriyapan, V |
2010 |
World journal of gastroenterology : WJG 19 (16), pp. 2362-70 |
|
| 2. | Crucial role of heme oxygenase-1 on the sensitivity of cholangiocarcinoma cells to chemotherapeutic agents. | Kongpetch, S Kukongviriyapan, V Prawan, A Senggunprai, L Kukongviriyapan, U Buranrat, B |
2012 |
PloS one 4 (7), pp. e34994 |
|
| 3. | Luteolin arrests cell cycling, induces apoptosis and inhibits the JAK/STAT3 pathway in human cholangiocarcinoma cells. | Aneknan, P Kukongviriyapan, V Prawan, A Kongpetch, S Sripa, B Senggunprai, L |
2014 |
Asian Pacific journal of cancer prevention : APJCP 12 (15), pp. 5071-6 |
|
| 4. | Fumarate Hydratase-deficient Cell Line NCCFH1 as a New In Vitro Model of Hereditary Papillary Renal Cell Carcinoma Type 2. | Perrier-Trudova, V Huimin, BW Kongpetch, S Huang, D Ong, P LE Formal, A Poon, SL Siew, EY Myint, SS Gad, S Gardie, B Couvé, S Foong, YM Choudhury, Y Poh, J Ong, CK Toh, CK Ooi, A Richard, S Tan, MH Teh, BT |
2015 |
Anticancer research 12 (35), pp. 6639-53 |
|
| 5. | Pathogenesis of cholangiocarcinoma: From genetics to signalling pathways. | Kongpetch, S Jusakul, A Ong, CK Lim, WK Rozen, SG Tan, P Teh, BT |
2015 |
Best practice & research. Clinical gastroenterology 2 (29), pp. 233-44 |
|
| 6. | Genetics of Opisthorchis viverrini-related cholangiocarcinoma. | Jusakul, A Kongpetch, S Teh, BT |
2015 |
Current opinion in gastroenterology 3 (31), pp. 258-63 |
|
| 7. | Haem oxygenase 1 expression is associated with prognosis in cholangiocarcinoma patients and with drug sensitivity in xenografted mice. | Kongpetch, S Puapairoj, A Ong, CK Senggunprai, L Prawan, A Kukongviriyapan, U Chan-On, W Siew, EY Khuntikeo, N Teh, BT Kukongviriyapan, V |
2016 |
Cell proliferation 1 (49), pp. 90-101 |
|
| 8. | Downregulation of NAD(P)H:quinone oxidoreductase 1 inhibits proliferation, cell cycle and migration of cholangiocarcinoma cells. | Butsri, S Kukongviriyapan, V Senggunprai, L Kongpetch, S Zeekpudsa, P Prawan, A |
2017 |
Oncology letters 6 (13), pp. 4540-4548 |
|
| 9. | Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma. | Jusakul, A Cutcutache, I Yong, CH Lim, JQ Huang, MN Padmanabhan, N Nellore, V Kongpetch, S Ng, AWT Ng, LM Choo, SP Myint, SS Thanan, R Nagarajan, S Lim, WK Ng, CCY Boot, A Liu, M Ong, CK Rajasegaran, V Lie, S Lim, AST Lim, TH Tan, J Loh, JL McPherson, JR Khuntikeo, N Bhudhisawasdi, V Yongvanit, P Wongkham, S Totoki, Y Nakamura, H Arai, Y Yamasaki, S Chow, PK Chung, AYF Ooi, LLPJ Lim, KH Dima, S Duda, DG Popescu, I Broet, P Hsieh, SY Yu, MC Scarpa, A Lai, J Luo, DX Carvalho, AL Vettore, AL Rhee, H Park, YN Alexandrov, LB Gordân, R Rozen, SG Shibata, T Pairojkul, C Teh, BT Tan, P |
2017 |
Cancer discovery 10 (7), pp. 1116-1135 |
|
| 10. | Metformin enhances cisplatin induced inhibition of cholangiocarcinoma cells via AMPK-mTOR pathway. | Wandee, J Prawan, A Senggunprai, L Kongpetch, S Tusskorn, O Kukongviriyapan, V |
2018 |
Life sciences (207), pp. 172-183 |
|
| 11. | Metformin sensitizes cholangiocarcinoma cell to cisplatin-induced cytotoxicity through oxidative stress mediated mitochondrial pathway. | Wandee, J Prawan, A Senggunprai, L Kongpetch, S Kukongviriyapan, V |
2019 |
Life sciences (217), pp. 155-163 |
|
| 12. | Cucurbitacin B induces mitochondrial-mediated apoptosis pathway in cholangiocarcinoma cells via suppressing focal adhesion kinase signaling. | Klungsaeng, S Kukongviriyapan, V Prawan, A Kongpetch, S Senggunprai, L |
2019 |
Naunyn-Schmiedeberg's archives of pharmacology 3 (392), pp. 271-278 |
|
| 13. | Myricetin ameliorates cytokine-induced migration and invasion of cholangiocarcinoma cells via suppression of STAT3 pathway. | Tuponchai, P Kukongviriyapan, V Prawan, A Kongpetch, S Senggunprai, L |
2019 |
Journal of cancer research and therapeutics 1 (15), pp. 157-163 |
|
| 14. | Targeted Modulation of FAK/PI3K/PDK1/AKT and FAK/p53 Pathways by Cucurbitacin B for the Antiproliferation Effect Against Human Cholangiocarcinoma Cells. | Klungsaeng, S Kukongviriyapan, V Prawan, A Kongpetch, S Senggunprai, L |
2020 |
The American journal of Chinese medicine (), pp. 1-15 |
|
| 15. | Lack of Targetable FGFR2 Fusions in Endemic Fluke-Associated Cholangiocarcinoma. | Kongpetch, S Jusakul, A Lim, JQ Ng, CCY Chan, JY Rajasegaran, V Lim, TH Lim, KH Choo, SP Dima, S Popescu, I Duda, DG Kukongviriyapan, V Khuntikeo, N Pairojkul, C Rozen, SG Tan, P Teh, BT |
2020 |
JCO global oncology (6), pp. 628-638 |
|
| 16. | Phenformin inhibits proliferation, invasion, and angiogenesis of cholangiocarcinoma cells via AMPK-mTOR and HIF-1A pathways. | Jaidee, R Kongpetch, S Senggunprai, L Prawan, A Kukongviriyapan, U Kukongviriyapan, V |
2020 |
Naunyn-Schmiedeberg's archives of pharmacology 9 (393), pp. 1681-1690 |
|
| 17. | Cucurbitacin B Diminishes Metastatic Behavior of Cholangiocarcinoma Cells by Suppressing Focal Adhesion Kinase. | Kaewmeesri, P Kukongviriyapan, V Prawan, A Kongpetch, S Senggunprai, L |
2021 |
Asian Pacific journal of cancer prevention : APJCP 1 (22), pp. 219-225 |
|
| 18. | Targeting FGFR inhibition in cholangiocarcinoma. | Goyal, L Kongpetch, S Crolley, VE Bridgewater, J |
2021 |
Cancer treatment reviews (95), pp. 102170 |
|
| 19. | Derrischalcone suppresses cholangiocarcinoma cells through targeting ROS-mediated mitochondrial cell death, Akt/mTOR, and FAK pathways. | Wandee, J Srinontong, P Prawan, A Senggunprai, L Kongpetch, S Yenjai, C Kukongviriyapan, V |
2021 |
Naunyn-Schmiedeberg's archives of pharmacology 9 (394), pp. 1929-1940 |
|
| 20. | Arctigenin inhibits cholangiocarcinoma progression by regulating cell migration and cell viability via the N-cadherin and apoptosis pathway. | Janthamala, S Jusakul, A Kongpetch, S Kimawaha, P Klanrit, P Loilome, W Namwat, N Techasen, A |
2021 |
Naunyn-Schmiedeberg's archives of pharmacology 10 (394), pp. 2049-2059 |
|
| 21. | Anti-metastatic Potential of Natural Triterpenoid Cucurbitacin B Against Cholangiocarcinoma Cells by Targeting Src Protein. | Kaewmeesri, P Pocasap, P Kukongviriyapan, V Prawan, A Kongpetch, S Senggunprai, L |
2022 |
Integrative cancer therapies (21), pp. 15347354221124861 |
|
| 22. | Therapeutic targeting of ARID1A and PI3K/AKT pathway alterations in cholangiocarcinoma. | Tessiri, S Techasen, A Kongpetch, S Namjan, A Loilome, W Chan-On, W Thanan, R Jusakul, A |
2022 |
PeerJ (10), pp. e12750 |
|
| 23. | Licochalcone A Induces Cholangiocarcinoma Cell Death Via Suppression of Nrf2 and NF-κB Signaling Pathways. | Laphanuwat, P Kongpetch, S Senggunprai, L Prawan, A Kukongviriyapan, V |
2022 |
Asian Pacific journal of cancer prevention : APJCP 1 (23), pp. 115-123 |
|
| 24. | Inhibition of FGFR2 enhances chemosensitivity to gemcitabine in cholangiocarcinoma through the AKT/mTOR and EMT signaling pathways. | Jaidee, R Kukongviriyapan, V Senggunprai, L Prawan, A Jusakul, A Laphanuwat, P Kongpetch, S |
2022 |
Life sciences (), pp. 120427 |
|
| 25. | All--retinoic acid induces RARB-dependent apoptosis via ROS induction and enhances cisplatin sensitivity by NRF2 downregulation in cholangiocarcinoma cells. | Butsri, S Kukongviriyapan, V Senggunprai, L Kongpetch, S Prawan, A |
2022 |
Oncology letters 6 (23), pp. 179 |
|
| 26. | Epidermal growth factor receptor as a potential target of momordin Ic to promote apoptosis of cholangiocarcinoma cells. | Senggunprai, L Kukongviriyapan, V Prawan, A Kongpetch, S |
2022 |
The Journal of pharmacy and pharmacology 7 (74), pp. 996-1005 |
|
| 27. | FGF10/FGFR2 Signaling: Therapeutically Targetable Vulnerability in Ligand-responsive Cholangiocarcinoma Cells. | Oeurn, K Jusakul, A Jaidee, R Kukongviriyapan, V Senggunprai, L Prawan, A Kongpetch, S |
2023 |
In vivo (Athens, Greece) 4 (37), pp. 1628-1637 |
|
| 28. | Alteration of STK11 Expression Associated With Cholangiocarcinoma Progression. | Sirithawat, P Jusakul, A Kongpetch, S Thanee, M Srichanchara, P Panjaroensak, S Kimawaha, P Janthamala, S Aphivatanasiri, C Techasen, A |
2023 |
In vivo (Athens, Greece) 4 (37), pp. 1638-1648 |
|
| 29. | Network pharmacology- and cell-based assessments identify the FAK/Src pathway as a molecular target for the antimetastatic effect of momordin Ic against cholangiocarcinoma. | Pocasap, P Prawan, A Kongpetch, S Senggunprai, L |
2024 |
Heliyon 11 (10), pp. e32352 |
|
| 30. | Integrative multiomics enhancer activity profiling identifies therapeutic vulnerabilities in cholangiocarcinoma of different etiologies. | Hong, JH Yong, CH Heng, HL Chan, JY Lau, MC Chen, J Lee, JY Lim, AH Li, Z Guan, P Chu, PL Boot, A Ng, SR Yao, X Wee, FYT Lim, JCT Liu, W Wang, P Xiao, R Zeng, X Sun, Y Koh, J Kwek, XY Ng, CCY Klanrit, P Zhang, Y Lai, J Tai, DWM Pairojkul, C Dima, S Popescu, I Hsieh, SY Yu, MC Yeong, J Kongpetch, S Jusakul, A Loilome, W Tan, P Tan, J Teh, BT |
2024 |
Gut 6 (73), pp. 966-984 |
|
| 31. | Dual blockage of PI3K-mTOR and FGFR induced autophagic cell death in cholangiocarcinoma cells. | Mahaamnad, N Pocasap, P Kukongviriyapan, V Senggunprai, L Prawan, A Kongpetch, S |
2024 |
Heliyon 10 (10), pp. e31112 |
|
| 32. | Anticancer properties and metabolomic profiling of Shorea roxburghii extracts toward gastrointestinal cancer cell lines. | Janthamala, S Promraksa, B Thanee, M Duenngai, K Jusakul, A Kongpetch, S Kraiklang, R Thanee, K Pinlaor, P Namwat, N Saya, H Techasen, A |
2024 |
BMC complementary medicine and therapies 1 (24), pp. 178 |
|
| 33. | Synergistic suppression of cholangiocarcinoma cells via DNA damage response and cell cycle arrest by dual targeting PARP and ATM in DNA damage repair pathway. | Jaidee, R Pocasap, P Jusakul, A Senggunprai, L Prawan, A Hong, JH Heng, HL Kukongviriyapan, V Teh, BT Kongpetch, S |
2025 |
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (189), pp. 118273 |
|
| 34. | Establishment and genomic profiling of cholangiocarcinoma cells with functional characterization. | Jaidee, R Jusakul, A Pocasap, P Kukongviriyapan, V Senggunprai, L Prawan, A Loilome, W Titapun, A Jareanrat, A Thanasukarn, V Khuntikeo, N Namwat, N Chamgramol, Y Thanee, M Wichian, P Hong, JH Guan, P Heng, HL Pairojkul, C Teh, BT Kongpetch, S |
2025 |
Scientific reports 1 (15), pp. 8621 |
|
| 35. | Mutations in Cholangiocarcinoma: Prevalence, Prognostic Value, and G12/G13 Detection in Cell-Free DNA. | Thongyoo, P Chindaprasirt, J Aphivatanasiri, C Intarawichian, P Kunprom, W Kongpetch, S Techasen, A Loilome, W Namwat, N Titapun, A Jusakul, A |
2025 |
Cancer genomics & proteomics 1 (22), pp. 112-126 |
|
| 36. | Expression and Prognostic Implication of the Nuclear Receptors Farnesoid X Receptor and Pregnane X Receptor in Human Cholangiocarcinoma. | Sa-Ngiamwibool, P Yoshinari, K Shizu, R Kongpetch, S Prawan, A Senggunprai, L |
2025 |
Cancer diagnosis & prognosis 4 (5), pp. 529-541 |
|
| 37. | Redox modulation and human bile duct cancer inhibition by curcumin. | Suphim, B Prawan, A Kukongviriyapan, U Kongpetch, S Buranrat, B Kukongviriyapan, V |
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 8 (48), pp. 2265-72 |
| Title | Authors | Year | Journal title | Cited count | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| < 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Total | ||||||
| 1. | Dicoumarol enhances gemcitabine-induced cytotoxicity in high NQ01-expressing cholangiocarcinoma cells | Benjaporn Buranrat Auemduan Prawan Upa Kukongviriyapan Sarinya Kongpetch Veerapol Kukongviriyapan |
2010 |
WORLD JOURNAL OF GASTROENTEROLOGY 19.0 (16.0), pp. 2362.0-2370.0 |
53 | 0 | 0 | 0 | 0 | 0 | 53 | |
| 2. | Redox modulation and human bile duct cancer inhibition by curcumin | Bunliang Suphim Auemduan Prawan Upa Kukongviriyapan Sarinya Kongpetch Benjaporn Buranrat Veerapol Kukongviriyapan |
2010 |
FOOD AND CHEMICAL TOXICOLOGY 8-9 (48.0), pp. 2265.0-2272.0 |
34 | 0 | 0 | 0 | 0 | 0 | 34 | |
| 3. | Crucial Role of Heme Oxygenase-1 on the Sensitivity of Cholangiocarcinoma Cells to Chemotherapeutic Agents | Sarinya Kongpetch Veerapol Kukongviriyapan Auemduan Prawan Laddawan Senggunprai Upa Kukongviriyapan Benjaporn Buranrat |
2012 |
PLOS ONE 4.0 (7.0), pp. |
73 | 0 | 0 | 0 | 0 | 0 | 73 | |
| 4. | Heme oxygenase-1 as a potential target for anticancer treatments in cholangiocarcinoma | S. Kongpetch V. Kukongviriyapan A. Prawan L. Senggunprai U. Kukongviriyapan O. C. Kiat W. Chan-On S. E. Yan T. B. Tean |
2012 |
FEBS JOURNAL (279.0), pp. 102.0-102.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 5. | Luteolin Arrests Cell Cycling, Induces Apoptosis and Inhibits the JAK/STAT3 Pathway in Human Cholangiocarcinoma Cells | Ploypailin Aneknan Veerapol Kukongviriyapan Auemduan Prawan Sarinya Kongpetch Banchob Sripa Laddawan Senggunprai |
2014 |
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION 12.0 (15.0), pp. 5071.0-5076.0 |
70 | 0 | 0 | 0 | 0 | 0 | 70 | |
| 6. | Fumarate Hydratase-deficient Cell Line NCCFH1 as a New In Vitro Model of Hereditary Papillary Renal Cell Carcinoma Type 2 | Victoria Perrier-Trudova Bernice Wong Huimin Sarinya Kongpetch Dachuan Huang Pauline Ong Audrey Le Formal Song Ling Poon Ee Yan Siew Swe Swe Myint Sophie Gad Betty Gardie Sophie Couve Yu Miin Foong Yukti Choudhury Jonathan Poh Choon Kiat Ong Chee Keong Toh Aikseng Ooi Stephane Richard Min-Han Tan Bin Tean Teh |
2015 |
ANTICANCER RESEARCH 12.0 (35.0), pp. 6639.0-6653.0 |
16 | 0 | 0 | 0 | 0 | 0 | 16 | |
| 7. | Genetics of Opisthorchis viverrini-related cholangiocarcinoma | Apinya Jusakul Sarinya Kongpetch Bin Tean Teh |
2015 |
CURRENT OPINION IN GASTROENTEROLOGY 3.0 (31.0), pp. 258.0-263.0 |
38 | 0 | 0 | 0 | 0 | 0 | 38 | |
| 8. | Pathogenesis of cholangiocarcinoma: From genetics to signalling pathways | Sarinya Kongpetch Apinya Jusakul Choon Kiat Ong Weng Khong Lim Steven G. Rozen Patrick Tan Bin Tean Teh |
2015 |
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY 2.0 (29.0), pp. 233.0-244.0 |
36 | 0 | 0 | 0 | 0 | 0 | 36 | |
| 9. | Haem oxygenase 1 expression is associated with prognosis in cholangiocarcinoma patients and with drug sensitivity in xenografted mice | S. Kongpetch A. Puapairoj C. K. Ong L. Senggunprai A. Prawan U. Kukongviriyapan W. Chan-On E. Y. Siew N. Khuntikeo B. T. Teh V. Kukongviriyapan |
2016 |
CELL PROLIFERATION 1.0 (49.0), pp. 90.0-101.0 |
19 | 0 | 0 | 0 | 0 | 0 | 19 | |
| 10. | Downregulation of NAD(P)H:quinone oxidoreductase 1 inhibits proliferation, cell cycle and migration of cholangiocarcinoma cells | Siriwoot Butsri Veerapol Kukongviriyapan Laddawan Senggunprai Sarinya Kongpetch Ponsilp Zeekpudsa Auemduan Prawan |
2017 |
ONCOLOGY LETTERS 6.0 (13.0), pp. 4540.0-4548.0 |
32 | 0 | 0 | 0 | 0 | 0 | 32 | |
| 11. | SILENCING OF NAD(P) H: QUINONE OXIDOREDUCTASE 1 DECREASES THE CELL GROWTH AND MIGRATION OF CHOLANGIOCARCINOMA CELLS | Auemduan Prawan Siriwoot Butsri Veerapol Kukongviriyapan Laddawan Senggunprai Sarinya Kongpetch |
2017 |
DRUG METABOLISM AND PHARMACOKINETICS 1.0 (32.0), pp. S84-S84 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 12. | Antitumor effects of candidone, a natural flavanone derivative, in cholangiocarcinoma cells | Sarinya Kongpetch Benjawan Kurasug Veerapol Kukongviriyapan Auemduan Prawan Laddawan Senggunprai Chavi Yenjai |
2018 |
CANCER SCIENCE (109.0), pp. 558.0-558.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 13. | Antitumor effects of candidone extracted from Derris indica (Lamk) Bennet in cholangiocarcinoma cells | Benjawan Kurasug Veerapol Kukongviriyapan Auemduan Prawan Chavi Yenjai Sarinya Kongpetch |
2018 |
TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH 7.0 (17.0), pp. 1337.0-1343.0 |
1 | 0 | 0 | 0 | 0 | 0 | 1 | |
| 14. | Cucurbitacin B induces apoptosis in human cholangiocarcinoma cells by modulation of apoptotic-related proteins | Sirinapha Klungsaeng Laddawan Senggunprai Veerapol Kukongviriyapan Auemduan Prawan Sarinya Kongpetch |
2018 |
CANCER SCIENCE (109.0), pp. 1047.0-1047.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 15. | Metformin enhances cisplatin induced inhibition of cholangiocarcinoma cells via AMPK-mTOR pathway | Jaroon Wandee Auemduan Prawan Laddawan Senggunprai Sarinya Kongpetch Ornanong Tusskorn Veerapol Kukongviriyapan |
2018 |
LIFE SCIENCES (207.0), pp. 172.0-183.0 |
33 | 0 | 0 | 0 | 0 | 0 | 33 | |
| 16. | Migration of Pancreatic Cancer cell BxPC-3 is suppressed by ROS | Jaroon Wandee Auemduan Prawan Laddawan Senggunprai Sarinya Kongpetch Veerapol Kukongviriyapan |
2018 |
CANCER SCIENCE (109.0), pp. 246.0-246.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 17. | Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma | Apinya Jusakul Ioana Cutcutache Chern Han Yong Jing Quan Lim Mi Ni Huang Nisha Padmanabhan Vishwa Nellore Sarinya Kongpetch Alvin Wei Tian Ng Ley Moy Ng Su Pin Choo Swe Swe Myint Raynoo Thanan Sanjanaa Nagarajan Weng Khong Lim Cedric Chuan Young Ng Arnoud Boot Mo Liu Choon Kiat Ong Vikneswari Rajasegaran Stefanus Lie Alvin Soon Tiong Lim Tse Hui Lim Jing Tan Jia Liang Loh John R. McPherson Narong Khuntikeo Vajaraphongsa Bhudhisawasdi Puangrat Yongvanit Sopit Wongkham Yasushi Totoki Hiromi Nakamura Yasuhito Arai Satoshi Yamasaki Pierce Kah-Hoe Chow Alexander Yaw Fui Chung London Lucien Peng Jin Ooi Kiat Hon Lim Simona Dima Dan G. Duda Irinel Popescu Philippe Broet Sen-Yung Hsieh Ming-Chin Yu Aldo Scarpa Jiaming Lai Di-Xian Luo Andre Lopes Carvalho Andre Luiz Vettore Hyungjin Rhee Young Nyun Park Ludmil B. Alexandrov Raluca Gordan Steven G. Rozen Tatsuhiro Shibata Chawalit Pairojkul Bin Tean Teh Patrick Tan |
2018 |
CANCER SCIENCE (109.0), pp. 720.0-720.0 |
243 | 0 | 0 | 0 | 0 | 0 | 243 | |
| 18. | Cucurbitacin B induces mitochondrial-mediated apoptosis pathway in cholangiocarcinoma cells via suppressing focal adhesion kinase signaling | Sirinapha Klungsaeng Veerapol Kukongviriyapan Auemduan Prawan Sarinya Kongpetch Laddawan Senggunprai |
2019 |
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY 3.0 (392.0), pp. 271.0-278.0 |
8 | 0 | 0 | 0 | 0 | 0 | 8 | |
| 19. | Metformin sensitizes cholangiocarcinoma cell to cisplatin-induced cytotoxicity through oxidative stress mediated mitochondrial pathway | Jaroon Wandee Auemduan Prawan Laddawan Senggunprai Sarinya Kongpetch Veerapol Kukongviriyapan |
2019 |
LIFE SCIENCES (217.0), pp. 155.0-163.0 |
22 | 0 | 0 | 0 | 0 | 0 | 22 | |
| 20. | Myricetin ameliorates cytokine-induced migration and invasion of cholangiocarcinoma cells via suppression of STAT3 pathway | Pattarapon Tuponchai Veerapol Kukongviriyapan Auemduan Prawan Sarinya Kongpetch Laddawan Senggunprai |
2019 |
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS 1.0 (15.0), pp. 157.0-163.0 |
15 | 0 | 0 | 0 | 0 | 0 | 15 | |
| 21. | Lack of Targetable FGFR2 Fusions in Endemic Fluke-Associated Cholangiocarcinoma | Sarinya Kongpetch Apinya Jusakul Jing Quan Lim Cedric Chuan Young Ng Jason Yongsheng Chan Vikneswari Rajasegaran Tse Hui Lim Kiat Hon Lim Su Pin Choo Simona Dima Irinel Popescu Dan G. Duda Veerapol Kukongviriyapan Narong Khuntikeo Chawalit Pairojkul Steven G. Rozen Patrick Tan Bin Tean Teh |
2020 |
JCO GLOBAL ONCOLOGY (6.0), pp. 628.0-638.0 |
7 | 0 | 0 | 0 | 0 | 0 | 7 | |
| 22. | Phenformin inhibits proliferation, invasion, and angiogenesis of cholangiocarcinoma cells via AMPK-mTOR and HIF-1A pathways | Rattanaporn Jaidee Sarinya Kongpetch Laddawan Senggunprai Auemduan Prawan Upa Kukongviriyapan Veerapol Kukongviriyapan |
2020 |
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY 9.0 (393.0), pp. 1681.0-1690.0 |
4 | 0 | 0 | 0 | 0 | 0 | 4 | |
| 23. | Rice bran hydrolysates induce immunomodulatory effects by suppression of chemotaxis, and modulation of cytokine release and cell-mediated cytotoxicity | Suphanthip Phusrisom Laddawan Senggunprai Auemduan Prawan Sarinya Kongpetch Upa Kukongviriyapan Supawan Thawornchinsombut Ronnachai Changsri Veerapol Kukongviriyapan |
2020 |
ASIAN PACIFIC JOURNAL OF TROPICAL BIOMEDICINE 10.0 (10.0), pp. 470.0-478.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 24. | Targeted Modulation of FAK/PI3K/PDK1/AKT and FAK/p53 Pathways by Cucurbitacin B for the Antiproliferation Effect Against Human Cholangiocarcinoma Cells | Sirinapha Klungsaeng Veerapol Kukongviriyapan Auemduan Prawan Sarinya Kongpetch Laddawan Senggunprai |
2020 |
AMERICAN JOURNAL OF CHINESE MEDICINE 6.0 (48.0), pp. 1475.0-1489.0 |
2 | 0 | 0 | 0 | 0 | 0 | 2 | |
| 25. | Anti-tumor activity of rice bran hydrolysates on migration, invasion and angiogenesis | Suphanthip Phusrisom Laddawan Senggunprai Auemduan Prawan Sarinya Kongpetch Upa Kukongviriyapan Supawan Thawornchinsombut Sirithon Siriamornpun Theeraphan Chumroenphat Ronnachai Changsri Veerapol Kukongviriyapan |
2021 |
ASIAN PACIFIC JOURNAL OF TROPICAL BIOMEDICINE 7.0 (11.0), pp. 317.0-326.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 26. | Arctigenin inhibits cholangiocarcinoma progression by regulating cell migration and cell viability via the N-cadherin and apoptosis pathway | Sutthiwan Janthamala Apinya Jusakul Sarinya Kongpetch Phongsaran Kimawaha Poramate Klanrit Watcharin Loilome Nisana Namwat Anchalee Techasen |
2021 |
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY 10.0 (394.0), pp. 2049.0-2059.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 27. | Derrischalcone suppresses cholangiocarcinoma cells through targeting ROS-mediated mitochondrial cell death, Akt/mTOR, and FAK pathways | Jaroon Wandee Piyarat Srinontong Auemduan Prawan Laddawan Senggunprai Sarinya Kongpetch Chavi Yenjai Veerapol Kukongviriyapan |
2021 |
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY 9.0 (394.0), pp. 1929.0-1940.0 |
1 | 0 | 0 | 0 | 0 | 0 | 1 | |
| 28. | Diagnostic and Prognostic Value of Circulating Cell-Free DNA for Cholangiocarcinoma | Preawwalee Wintachai Jing Quan Lim Anchalee Techasen Worachart Lert-Itthiporn Sarinya Kongpetch Watcharin Loilome Jarin Chindaprasirt Attapol Titapun Nisana Namwat Narong Khuntikeo Apinya Jusakul |
2021 |
DIAGNOSTICS 6.0 (11.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 29. | Targeting FGFR inhibition in cholangiocarcinoma | Lipika Goyal Sarinya Kongpetch Valerie E. Crolley John Bridgewater |
2021 |
CANCER TREATMENT REVIEWS (95.0), pp. |
9 | 0 | 0 | 0 | 0 | 0 | 9 | |
| Title | Authors | Year | Journal title | ||
|---|---|---|---|---|---|
| 1. | Inhibition of Heme Oxygenase-1 Enhanced Antitumor Effect of Gemcitabine in Cholangiocarcinoma | Sarinya Kongpetch | 2013 |
Srinagarind Medical Journal (28 No 4), pp. 202 |
| Title | Authors | NRIIS type | Year | NRIIS Scholarship | ||
|---|---|---|---|---|---|---|
| 1. | Retinoid X receptor และ retinoic acid receptor: บทบาทและศักยภาพในการเป็นเป้าหมายของการรักษามะเร็งท่อน้ำดี. |
ผศ.ดร. เอื้อมเดือน ประวาฬ ศ.ดร. วีรพล คู่คงวิริยพันธุ์ รศ.ดร. ลัดดาวัลย์ เส็งกันไพร ผศ.ดร. ศริญญา คงเพชร |
โครงการย่อย ภายใต้ชุดโครงการวิจัย | 2561 | ทุนงบประมาณแผ่นดินประจำปี 2561 (งบบูรณาการวิจัยและนวัตกรรม) | |
| 2. | การปรับเปลี่ยนภาวะรีดอกซ์ภายในเซลล์ต่อการอยู่รอดและฟื้นฟูตัวเองเซลล์มะเร็งท่อน้ำดี |
ศ.ดร. วีรพล คู่คงวิริยพันธุ์ รศ.ดร. ลัดดาวัลย์ เส็งกันไพร ผศ.ดร. ศริญญา คงเพชร ผศ.ดร. เอื้อมเดือน ประวาฬ |
โครงการย่อย ภายใต้ชุดโครงการวิจัย | 2561 | ทุนงบประมาณแผ่นดินประจำปี 2561 (งบบูรณาการวิจัยและนวัตกรรม) | |
| 3. | ผลของสารสกัดจากClausena harmandianaในการยับยั้งยีนในวิถีantioxidant-response-elementที่ก่อมะเร็งท่อน้ำดี |
ผศ.ดร. ศริญญา คงเพชร ผศ.ดร. เอื้อมเดือน ประวาฬ ศ.ดร. วีรพล คู่คงวิริยพันธุ์ รศ.ดร. ลัดดาวัลย์ เส็งกันไพร |
โครงการย่อย ภายใต้ชุดโครงการวิจัย | 2561 | ทุนงบประมาณแผ่นดินประจำปี 2561 (งบบูรณาการวิจัยและนวัตกรรม) | |
| 4. | สารสกัดจาก Momordicacharantia Linn. มีเคมีบำบัดฤทธิ์สูงยับยั้ง transcription factor ก่อมะเร็งในมะเร็งท่อน้ำดี. |
รศ.ดร. ลัดดาวัลย์ เส็งกันไพร ผศ.ดร. ศริญญา คงเพชร ผศ.ดร. เอื้อมเดือน ประวาฬ ศ.ดร. วีรพล คู่คงวิริยพันธุ์ |
โครงการย่อย ภายใต้ชุดโครงการวิจัย | 2561 | ทุนงบประมาณแผ่นดินประจำปี 2561 (งบบูรณาการวิจัยและนวัตกรรม) | |
| 5. | การบำบัดทางเภสัชวิทยาโดยมีเป้าหมายที่วิถีสัญญาณก่อมะเร็ง: กลยุทธ์การรักษาที่มีคุณค่าสำหรับมะเร็งท่อน้ำดี |
ผศ.ดร. ศริญญา คงเพชร รศ.ดร. ลัดดาวัลย์ เส็งกันไพร ผศ.ดร. เอื้อมเดือน ประวาฬ |
ชุดโครงการวิจัย | 2562 | ทุนงบประมาณแผ่นดินประจำปี 2562 (งบบูรณาการวิจัยและนวัตกรรม) |